Bioretec Ltd  Company announcement 15 August 2024 at 8:00 a.m. TAMPERE, Finland, Aug. 15, 2024 /PRNewswire/ -- This announcement is a summary of Bioretec Ltd's half-year report January-June 2024. The complete half-year report with tables is attached to this release as a pdf file and available at the company's web pages at https://bioretec.com/investors/investors-in-english/releases. April-June 2024 in brief Net sales increased by 68% and amounted to EUR 1,379 thousand (4-6/2023: EUR 820 thousand). Sales margin (excl. other income) was EUR 1,033 (609) thousand, or 74.9% (74.3%) of net sales. Profit (loss) for the reporting period was EUR -787 (-1,518) thousand. The comparison period included the cost of financing arrangement amounting to EUR 795 thousand. January-June 2024 in brief Net sales amounted to EUR 2,061 thousand (1-6/2023: EUR 1,891 thousand). Sales margin (excl. other income) was EUR 1,451 (1,327) thousand or 70.4% (70.2%) of net sales. The sales margin in January-June 2024 includes other income of EUR 72 (0) thousand accrued relating to a Business Finland grant. Profit (loss) for the reporting period was EUR -1,884 (-2,075) thousand. Earnings per share (undiluted) were EUR -0.09 (-0.11). Key figures EUR 1,000 4-6/2024 4-6/2023 Change, % 1-6/2024 1-6/2023 Change, % 1-12/2023 Net sales 1,379 820 68.3 % 2,061 1,891 9.0 % 3,906 Sales margin 1,045 609 71.6 % 1,523 1,327 14.8 % 2,810 Sales margin (excl. other income) 1,033 609 69.8 % 1,451 1,327 9.4 % 2,728 Sales margin, % of net sales 75.7 74.3 73.9 % 70.2 % 71.9 % Sales margin% (excl. other income) 74.9 74.3 70.4 % 70.2 % 69.8 % EBITDA -752 -639 17.8 % -1,864 -1,130 65.0 % -2,833 EBIT -782 -690 13.4 % -1,921 -1,233 55.8 %